Google's DeepMind shouldn't suck up our NHS records in secret
By Randeep Ramesh,
The Guardian [US]
| 05. 04. 2016
Untitled Document
When it was revealed that Google’s London-based company DeepMind would be able to access the NHS records of 1.6 million patients who use three London hospitals run by the Royal Free NHS trust – Barnet, Chase Farm and the Royal Free – it rang alarm bells.
Not just because the British fiercely guard their intimate medical histories. Not just because Google, a sprawling octopus of a company with tentacles in all our lives, wishes to “organise the world’s information”. Not just because patients are unlikely to have consented to Google having this information.
The issue for many is the intertwining of these concerns with the idea of artificial intelligence (AI). DeepMind is no ordinary company. It specialises in AI, developing technology to exhibit something like intelligent reasoning.
Last year its engineers produced a research paper showing it had created a program that could replicate the work of a “professional human video games tester”. In March, Google’s DeepMind made history by creating a program that mastered the 3,000-year-old Chinese board game Go, thought to be beyond current technology because...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
